ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome (2019)
Source: Endocrine connections. Unidade: FM
Subjects: TRANSTORNOS DO DESENVOLVIMENTO SEXUAL, POLIMORFISMO, DENSIDADE ÓSSEA, MAMA, ÚTERO, TERAPIA DE REPOSIÇÃO DE ESTRÓGENOS, RECEPTORES DE ESTEROIDES
ABNT
SCALCO, Renata C; TRARBACH, Ericka B; ALBUQUERQUE, Edoarda V. A; et al. ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome. Endocrine connections, Bristol, v. 8, n. 11, p. 1513-1519, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/34275 > DOI: 10.1530/EC-19-0398.APA
Scalco, R. C., Trarbach, E. B., Albuquerque, E. V. A., Homma, T. K., Inoue-Lima, T. H., Nishi, M. Y., et al. (2019). ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome. Endocrine connections, 8( 11), 1513-1519. doi:10.1530/EC-19-0398NLM
Scalco RC, Trarbach EB, Albuquerque EVA, Homma TK, Inoue-Lima TH, Nishi MY, Mendonça BB de, Jorge AA de L. ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome [Internet]. Endocrine connections. 2019 ; 8( 11): 1513-1519.Available from: http://observatorio.fm.usp.br/handle/OPI/34275Vancouver
Scalco RC, Trarbach EB, Albuquerque EVA, Homma TK, Inoue-Lima TH, Nishi MY, Mendonça BB de, Jorge AA de L. ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome [Internet]. Endocrine connections. 2019 ; 8( 11): 1513-1519.Available from: http://observatorio.fm.usp.br/handle/OPI/34275